We are live on ! Find out more
ZCM

Zebra Capital Management Portfolio holdings

AUM $20M
1-Year Est. Return 2.24%
This Fund
S&P 500
This Quarter Est. Return
+18.5%
1 Year Est. Return
+2.24%
3 Year Est. Return
+142.1%
5 Year Est. Return
+107.07%
10 Year Est. Return
+252.16%
AUM
$90.8M
AUM Growth
+$12M
Cap. Flow
+$4.91M
Cap. Flow %
5.41%
Top 10 Hldgs %
18.38%
Holding
278
New
115
Increased
17
Reduced
37
Closed
109

Top Buys

Rank Stock Value
1
EBS icon
Emergent Biosolutions
EBS
+$2.15M
2
KELYA icon
Kelly Services Class A
KELYA
+$1.94M
3
ESGR
Enstar Group
ESGR
+$1.61M
4
LCII icon
LCI Industries
LCII
+$1.56M
5
UPBD icon
Upbound Group
UPBD
+$1.33M

Top Sells

Rank Stock Value
1
WDFC icon
WD-40
WDFC
+$1.47M
2
CORT icon
Corcept Therapeutics
CORT
+$1.23M
3
VCYT icon
Veracyte
VCYT
+$1.22M
4
CSTL icon
Castle Biosciences
CSTL
+$1.03M
5
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
+$965K

Sector Composition

Rank Sector Weight
1 Healthcare 20.12%
2 Industrials 15.8%
3 Financials 14.75%
4 Consumer Discretionary 13.38%
5 Technology 12.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HBB icon
101
Hamilton Beach Brands
HBB
$311M
$326K 0.36%
+18,001
New +$327K
AVD icon
102
American Vanguard Corp
AVD
$68.4M
$325K 0.36%
+15,924
New +$303K
APEI icon
103
American Public Education
APEI
$890M
$318K 0.35%
+8,921
New +$279K
RGP icon
104
Resources Connection
RGP
$151M
$315K 0.35%
+23,281
New +$300K
FMNB icon
105
Farmers National Banc Corp
FMNB
$939M
$313K 0.34%
+18,758
New +$275K
KBAL
106
DELISTED
Kimball International
KBAL
$310K 0.34%
22,180
-14,569
-40% -$189K
SRDX
107
DELISTED
Surmodics
SRDX
$307K 0.34%
5,479
-1,826
-25% -$91.1K
SRGA
108
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$306K 0.34%
4,665
+4,106
+735% +$286K
HBT icon
109
HBT Financial
HBT
$1.3B
$299K 0.33%
+17,432
New +$283K
EGRX
110
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$299K 0.33%
+7,170
New +$333K
ALTR
111
DELISTED
Altair Engineering Inc
ALTR
$296K 0.33%
+4,732
New +$289K
LPG icon
112
Dorian LPG
LPG
$2.03B
$294K 0.32%
+22,363
New +$297K
JYNT icon
113
The Joint Corp
JYNT
$118M
$292K 0.32%
+6,045
New +$227K
TVTX icon
114
Travere Therapeutics
TVTX
$5.2B
$292K 0.32%
11,684
-32,328
-73% -$893K
SGC icon
115
Superior Group of Companies
SGC
$185M
$291K 0.32%
+11,458
New +$286K
VYGR icon
116
Voyager Therapeutics
VYGR
$183M
$278K 0.31%
+59,124
New +$403K
MPAA icon
117
Motorcar Parts of America
MPAA
$254M
$273K 0.3%
+12,128
New +$267K
SNFCA icon
118
Security National Financial
SNFCA
$244M
$264K 0.29%
+37,768
New +$263K
EPAY
119
DELISTED
Bottomline Technologies Inc
EPAY
$263K 0.29%
+5,813
New +$280K
FSBW icon
120
FS Bancorp
FSBW
$319M
$262K 0.29%
+7,798
New +$241K
ILPT
121
Industrial Logistics Properties Trust
ILPT
$575M
$260K 0.29%
11,260
-5,372
-32% -$120K
SMBC icon
122
Southern Missouri Bancorp
SMBC
$852M
$258K 0.28%
6,548
-5,643
-46% -$202K
CASA
123
DELISTED
Casa Systems, Inc. Common Stock
CASA
$251K 0.28%
+26,387
New +$223K
ANIK icon
124
Anika Therapeutics
ANIK
$258M
$247K 0.27%
+6,044
New +$229K
SMBK icon
125
SmartFinancial
SMBK
$896M
$247K 0.27%
+11,434
New +$241K
3 4
5
6 7

Similar funds

CM
Cartica Management Washington, District of Columbia $20.9M AUM 14.51% 1-Year Est. Return
NPAM
Noble Path Asset Management New York $14.6M AUM 3.07% 1-Year Est. Return
6C
6elm Capital New York $33.3M AUM 34.31% 1-Year Est. Return
SCU
Spinnaker Capital (UK) London England, United Kingdom $5.4M AUM 7.99% 1-Year Est. Return
FFG
Ford Financial Group Fresno, California $2.36M AUM 7.29% 1-Year Est. Return
KE
KLP Enterprises Branford, Connecticut $1.97M AUM
GFT
Gilfoyle Foundation Trust New Fairfield, Connecticut $100 AUM
CCM
CTC Capital Management Chicago, Illinois $47.8M AUM 5.18% 1-Year Est. Return

Zebra Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Zebra Capital Management held 278 positions worth $90.8M, up 15% from $78.8M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Zebra Capital Management deployed $4.91M of net new capital in Q1 2021, opening 115 new positions and adding to 17 existing holdings. Its largest new stake was Emergent Biosolutions: 20,957 shares worth $1.95M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Veracyte, an estimated $1.22M trimmed.

  • Zebra Capital Management's largest Q1 2021 buy was Emergent Biosolutions: 20,957 shares worth $1.95M.
  • Zebra Capital Management added most to Rush Enterprises Class A in Q1 2021, an estimated $819K increase.
  • Zebra Capital Management's biggest Q1 2021 reduction was Veracyte, cutting an estimated $1.22M.
  • Zebra Capital Management fully exited WD-40 in Q1 2021, selling an estimated $1.47M.
  • Zebra Capital Management's ten largest holdings make up 18% of its $90.8M portfolio in Q1 2021.
  • Zebra Capital Management opened 115 new positions and closed 109 in Q1 2021.
  • Zebra Capital Management's portfolio value rose 15% quarter-over-quarter to $90.8M.

Based on Zebra Capital Management's 13F filing for Q1 2021, filed 17 May 2021.